You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

List of Excipients in API MOEXIPRIL HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing MOEXIPRIL HYDROCHLORIDE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
UCB Inc UNIVASC moexipril hydrochloride 0091-3707 CROSPOVIDONE
UCB Inc UNIVASC moexipril hydrochloride 0091-3707 FERRIC OXIDE RED
UCB Inc UNIVASC moexipril hydrochloride 0091-3707 GELATIN
UCB Inc UNIVASC moexipril hydrochloride 0091-3707 HYDROXYPROPYL CELLULOSE
UCB Inc UNIVASC moexipril hydrochloride 0091-3707 HYPROMELLOSES
UCB Inc UNIVASC moexipril hydrochloride 0091-3707 LACTOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing MOEXIPRIL HYDROCHLORIDE

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc moexipril hydrochloride 0093-0017 CROSPOVIDONE
Teva Pharmaceuticals USA Inc moexipril hydrochloride 0093-0017 FERRIC OXIDE RED
Teva Pharmaceuticals USA Inc moexipril hydrochloride 0093-0017 HYPROMELLOSE 2910
Teva Pharmaceuticals USA Inc moexipril hydrochloride 0093-0017 LACTOSE MONOHYDRATE
Teva Pharmaceuticals USA Inc moexipril hydrochloride 0093-0017 MAGNESIUM STEARATE
Teva Pharmaceuticals USA Inc moexipril hydrochloride 0093-0017 SODIUM BICARBONATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for MOEXIPRIL HYDROCHLORIDE

Excipient focus: COPOVIDONE

Excipient focus: CROSPOVIDONE

MOEXIPRIL HYDROCHLORIDE drug variants containing CROSPOVIDONE

Company Ingredient NDC
UCB Inc moexipril hydrochloride 0091-3707
Teva Pharmaceuticals USA Inc moexipril hydrochloride 0093-0017
Physicians Total Care Inc moexipril hydrochloride 54868-5928
Chartwell RX LLC moexipril hydrochloride 62135-967
Carilion Materials Management moexipril hydrochloride 68151-1472
Glenmark Pharmaceuticals Inc USA moexipril hydrochloride 68462-209
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM CARBONATE

Excipient focus: MAGNESIUM OXIDE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POVIDONE

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: STARCH, CORN

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: ZINC STEARATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links